PEW
- Product code
- PEW
- Device name
- Implantable Transprostatic Tissue Retractor System
- Device class
- Class 2
- 21 CFR
- 21 CFR 876.5530
- Medical specialty
- Gastroenterology, Urology
- Marketing pathway
- 510(K)
- Flag
- Implant
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 11 (all years; only the last 3 years are listed here)
FDA classification definition
The treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K232558 | 2023-09-22 | Neotract, Inc. | UroLift 2 ATC Advanced Tissue Control System | FDA |
Official FDA classification page: PEW
Classification and pathway per current FDA publications. Data from openFDA (CC0).